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a  b  s  t  r  a  c  t
Determination  of exposure  to  cyanide  can be accomplished  by direct  cyanide  analysis  or indirectly  by
analysis  of  cyanide  detoxification  products,  such  as  thiocyanate  and  2-amino-2-thiazoline-4-carboxylic
acid. A potentially  important  marker  and  detoxification  product  of  cyanide  exposure,  -ketoglutarate
cyanohydrin  (-KgCN),  is produced  by  the  reaction  of cyanide  and  -ketoglutarate.  Therefore,  an  ultra
high-performance  liquid  chromatography  tandem  mass  spectrometry  method  to  determine  -KgCN  in
plasma  was  developed.  Swine  plasma  was  spiked  with  -KgCN  and -KgCN-d4 (internal  standard)  and
proteins  were  precipitated  with  1% formic  acid in  acetonitrile.  After  centrifugation,  the  supernatant  was
dried,  reconstituted,  separated  by  reversed  phase  high  performance  liquid  chromatography  and  analyzed
by tandem  mass  spectrometry.  The  method  produced  a dynamic  range  of  0.3–50 M  and  a detection  limit
of  200  nM  for  -KgCN.  Furthermore,  the  method  produced  a %RSD  of  less  than 13% for  all  intra-  and  inter-
assay  analyses.  The  stability  of -KgCN  was poor  for most  storage  conditions  tested,  except  for  −80 ◦C,
which  produced  stable  concentrations  of  -KgCN  for the 30 days  tested.  The  validated  method  was  tested
by analysis  of -KgCN  in the  plasma  of  cyanide-exposed  swine.  -KgCN  was  not  detected  pre-exposure,
but  was  detected  in all post-exposure  plasma  samples  tested.  To  our  knowledge,  this  method  is the  first
reported  analytical  method  for  detecting  -KgCN  in  any  matrix.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
Cyanide exposure can occur in a variety of ways, including acci-
dental, suicidal, or homicidal. General population exposure can
occur through smoke inhalation from cigarettes or fires, consum-
ing cyanogenic glycosides found in foods, and working in industrial
facilities that use cyanide [1]. Furthermore, cyanide exposure can
also occur by the use of cyanide as a chemical warfare agent [2].
Once in the body, the toxicity of cyanide stems from its ability
to inhibit cytochrome c oxidase, thereby disrupting oxygen trans-
port to mitochondria [3]. Therefore, the confirmation of cyanide
exposure is important to administer treatment in a timely fashion
and monitor health conditions after exposure. The direct analy-
sis of cyanide to confirm exposure has serious limitations, due
to cyanide’s volatility, reactivity, and short half-life in biological
fluids [4–6]. Cyanide exists as both hydrogen cyanide (HCN) and
the cyanide ion (CN−) which are in rapid equilibrium with each
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other. Under normal biological conditions, cyanide exists mainly
as HCN, which is extremely volatile and rapidly eliminated from
biological matrices [4]. If cyanide exists as CN−, it is nucleophilic
and will rapidly react with various species in biological matrices,
thereby eliminating free cyanide from the sample [7]. These limita-
tions have led to the exploration of biomarker analysis for indirect
determination of cyanide exposure.
Indirect analysis of cyanide has mainly focused around thio-
cyanate and 2-amino-2-thiazoline-4-carboxylic acid (ATCA), the
major products of cyanide detoxification. Thiocyanate has shown
promise as a marker of cyanide exposure and various methods
exist for the analysis of thiocyanate in biological fluids [6]. How-
ever, disadvantages of thiocyanate analysis for cyanide exposure
have been reported. Ballantyne reported that thiocyanate con-
centrations fluctuated during various sample storage conditions
and recovery of thiocyanate from whole blood was  low [8]. Fur-
thermore, thiocyanate can be formed from metabolism of other
compounds besides cyanide [9]. ATCA has also shown promise
as an alternative marker of cyanide exposure and a few methods
have been developed for the analysis of ATCA in biological fluids
[7,10–12]. Although there is limited information on its relevance as
a biomarker for cyanide exposure, Petrikovics et al. suggested that
1570-0232/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
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Fig. 1. Proposed reaction pathway for the conversion of -Kg into -KgCN.
plasma ATCA might not be a good biomarker for cyanide exposure
based on a toxicokinetic study in rats [13]. Conversely, ATCA has
been suggested as an advantageous marker of long-term low-level
cyanide exposure [7,10–12]. Other markers of cyanide exposure
include cyanide-protein adducts [3,14,15] and cyanocobalamin
[16–18]. Cyanide-protein adducts may  serve as excellent long-term
markers of cyanide exposure, but the utility of this marker for rapid
analysis has not been assessed, and the synthesis of the standards
for this technique can be costly and demanding [19]. Although
cyanocobalamin is a potential marker, hydroxocobalamin, which
sequesters cyanide to form cyanocobalamin, is a treatment for
cyanide exposure [20–22]. Therefore, the use of hydroxocobalamin
as a treatment would convolute the use of cyanocobalamin as a
biomarker. Furthermore, detection of cyanocobalamin for cyanide
exposure is limited due to photodegradation [23,24]. Considering
the limitations concerning current biomarkers of cyanide exposure,
novel markers should be considered.
Cyanide is known to react with carbonyl compounds to form
cyanohydrins [25]. In biological systems, cyanide is converted to
-ketoglutarate cyanohydrin (-KgCN) through an equilibrium
reaction with -ketoglutarate (-Kg) (Fig. 1) [6]. Because -Kg
resides in the plasma [26], the ability to determine concentra-
tions of -KgCN may  allow for verification of cyanide exposure.
Therefore, the objective of this project was to develop an analytical
method to determine cyanide exposure by detection of -KgCN in
plasma. Because oral dosing of -Kg has been shown to mitigate the
toxicity of cyanide exposure [25,27–30], this method should also be
beneficial in aiding studies of -Kg as a therapeutic treatment for
CN− poisoning.
2. Experimental
2.1. Reagents and materials
All reagents were at least HPLC grade. Sodium cyanide (NaCN)
and all solvents were purchased from Fisher Scientific (Fair Lawn,
NJ, USA). -Kg and -ketoglutaric acid-d6 (-Kg-d6) were pur-
chased from Sigma–Aldrich (St. Louis, MO,  USA). LC/MS grade
formic acid was purchased from Thermo Scientific (Rockford, IL,
USA). Swine (Sus scrofa)  plasma (non-sterile with sodium citrate
anti-coagulant) was acquired from the Veterinary Science Depart-
ment at South Dakota State University. Cyanide-exposed swine
plasma was received from Wilford Hall Medical Center (Lackland
Air Force Base, TX). One animal (about 50 kg) was sedated, endotra-
cheally intubated, and maintained under anesthesia with inhaled
isoflurane. After acclimation, KCN (4 mg/mL) was infused intra-
venously (0.17 mg/kg/min) until apnea. Arterial blood was sampled
at baseline, 5 min  into cyanide infusion, at apnea, every 2 min  after
apnea for 10 min, and then every 10 min  for 60 min. Whole blood
(20 mL)  was withdrawn from the animal at each time point. The
blood (4 mL)  was then placed into EDTA tubes and centrifuged to
separate the plasma from the red blood cells, resulting in a final
plasma volume of 1 mL  for each sample. The plasma was  shipped
overnight on dry ice to South Dakota State University, where it was
immediately frozen upon arrival and stored at −80 ◦C until needed.
2.2. Synthesis of ˛-KgCN and ˛-KgCN-d4
-KgCN was synthesized according to an adapted procedure of
Green and Williamson [31], by first adding -Kg and an equimo-
lar amount of NaCN to water and stirring at room temperature for
30 min. The resulting solution was filtered and the solvent was
removed by rotary evaporation to afford a white, sticky product.
Characterization was achieved by 13C NMR, along with ESI-MS
operated in negative polarity mode. 13C NMR  (CD3OD,  400 MHz):
ı 178, 120, 70. ESI(−)-MS: m/z 172.0, 144.7, 101.0, 44.8. An
isotopically-labeled internal standard, -KgCN-d4 was synthesized
and characterized as described above for -KgCN, with -Kg-d6
replacing -Kg. 13C NMR  (CD3OD, 400 MHz): ı 178, 172, 122, 73.
ESI(−)-MS: m/z 176.1, 149.1, 105.1, 44.8. The characterization of
-KgCN and -KgCN-d4 by 13C NMR  did not show the presence of
-Kg. Furthermore, Green and Williamson [31] reported that no
free acid (-Kg) was  evident in their final product.
2.3. Sample preparation
Swine plasma (100 L) was  spiked with internal standard (IS),
-KgCN-d4 (20 L of 100 M),  and 1% formic acid in acetonitrile
(400 L) to initiate protein precipitation. The resulting solution
(pH of approximately 2), was  then vortexed for 5 min  and cen-
trifuged for 15 min  at 16,000×g (13,100 rpm, room temperature).
After centrifugation, an aliquot of the supernatant was transferred
to a 4 mL  screw-top vial and dried under N2(g) for 20 min  at room
temperature (Reacti-vap III, Pierce, Rockford, IL, USA). The volume
of supernatant transferred was evaluated at 100, 300, and 400 L,
with 300 L producing the optimum LC conditions in terms of
peak symmetry and band broadening. After drying, the sample was
reconstituted with formic acid (10 L of 10 M)  and water (300 L)
and was syringe-filtered (Teflon, 0.22 m)  to remove particulates.
The volume of water for reconstitution was  optimized at 300 L,
based on peak symmetry and band broadening. After filtration,
an aliquot (100 L) of the filtrate was  transferred to a glass insert
(150 L) which was  placed in a screw-top autosampler vial (2 mL)
and analyzed by ultra-high performance liquid chromatography
tandem mass spectrometry (UHPLC–MS–MS).
2.4. Analysis of ˛-KgCN
Analysis of -KgCN was conducted by UHPLC–MS–MS on a
Shimadzu UHPLC (LC-20AD, Shimadzu Corp., Kyoto, JPN) and an
AB Sciex Q-trap 5500 MS  (Applied Biosystems, Foster City, CA,
USA). Samples were separated by reversed-phase (RP) chromatog-
raphy using a Phenomenex Synergi 2.5  Fusion-RP 100 A˚ column
(2.00 × 50 mm)  (Phenomenex, Torrance, CA, USA). Mobile phases
consisted of 1% formic acid in H2O (mobile phase A, pH 2.1) and
1% formic acid in MeOH (mobile phase B). An aliquot (10 L) of
the sample was  separated by gradient flow at 40 ◦C with a flow
rate of 0.15 mL/min. The concentration of B was increased from 0%
to 100% over 2 min, held at 100% for 1 min, and then ramped back
down to 0% over 1 min  and held constant for 2 min  to re-equilibrate
the column between samples. Detection of -KgCN was  achieved
using electrospray ionization (ESI)–MS–MS operating in negative
polarity. N2 (50 psi) was  used as the curtain gas. The ion source was
operated at −4500 V and a temperature of 750 ◦C with a flow rate of
90.0 psi for both the nebulizer (GS1) and heater (GS2) gasses. The
collision cell was  operated with an entrance potential of −10.0 V
and a collision potential of −11.0 V at a medium collision gas (N2)
flow rate. -KgCN and -KgCN-d4 were analyzed in the MS  by mul-
tiple reaction monitoring (MRM)  with the parameters outlined in
Table 1.
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Table  1
Selected MRM  transitions, optimized declustering potentials (DPs) and collision energies (CEs) for the detection of -KgCN and -KgCN-d4 by MS–MS analysis.
Compounds Q1 Mass (m/z) Q3 Mass (m/z) Time (ms) DP (V) CE (V)
-KgCN (quantitation) 172.0 145.1 40.0 −26.47 −11.53
-KgCN (identification) 172.0 57.0 40.0 −32.85 −24.82
-KgCN-d4 (quantitation) 176.1 149.0 40.0 −26.92 −13.28
-KgCN-d4 (identification) 176.1 61.2 40.0 −31.76 −29.00
2.5. Calibration and quantification
-KgCN spiked swine plasma calibration standards (0.2, 0.3, 0.5,
1, 3, 5, 10, 30, 50, 100, and 300 M)  were prepared and analyzed
to evaluate the linear range. Quality control (QC) standards at low,
medium, and high concentrations (0.75, 4, and 20 M)  were used
to determine the inter- and intra-assay accuracy and precision. The
intra-assay accuracy and precision were determined over 1 day
with quintuplicate analysis of each QC standard, and inter-assay
accuracy and precision were evaluated over 3 days (within a 9 cal-
endar day period) with quintuplicate analysis of the QC standards
each day.
2.6. Stability and recovery
The stability of -KgCN in swine plasma was assessed at each
storage condition using low (0.75 M)  and high (20 M)  QC stan-
dards (each in triplicate). Short-term stability experiments were
evaluated for the stability of -KgCN in the autosampler (prepared
samples), on the bench-top, and over multiple freeze-thaw cycles.
For autosampler stability, QC standards were prepared, placed in
an autosampler at 15 ◦C, and analyzed at 0, 2, 4, 8, 12 and 24 h.
For bench-top stability, the QC standards were allowed to stand
at room temperature for 0, 2, 4, 8, 12 and 24 h prior to analysis.
Freeze-thaw stability was conducted over three cycles after the QC
standards were initially analyzed (cycle 0). Each cycle consisted
of storage at −80 ◦C for 24 h, thawing the standards unassisted at
room temperature, preparing and analyzing the applicable QC stan-
dards, and refreezing the remaining (non-analyzed) standards. This
protocol was continued until three cycles had elapsed. Long-term
stability experiments were also conducted under various storage
conditions (−80, −20 and 4 ◦C) for various times (0, 1, 2, 5, 12, 20,
and 30 days). Low and high QC standards were prepared and stored
at the desired temperature until analyzed.
Recovery experiments were conducted in order to determine
the ability of the sample preparation protocol to extract -KgCN
from swine plasma. Swine plasma was spiked with -KgCN at low,
medium, and high QC concentrations and compared to aqueous -
KgCN samples at the same nominal concentrations. The recovery
was calculated as a percentage by dividing the concentration of
the low, medium, and high QC standards in plasma (n = 5 for each)
against the same concentration of aqueous -KgCN (n = 5 for each).
2.7. Data analysis
Calibration curves were developed by plotting the ratio of the
MRM  (172.0–145.1 m/z) peak area for the analyte (-KgCN) and
the MRM  (176.1–149.0 m/z) peak area for the internal standard
(-KgCN-d4) as a function of the -KgCN concentration (M) in
plasma. Both weighted (1/x  and 1/x2) and unweighted calibration
curves were prepared by least squares and a weighted (1/x2) lin-
ear fit was found to best fit the calibration data as determined
by the inspection of residual plots. The limit-of-detection (LOD)
was determined at a signal-to-noise ratio of 3 over 3 separate
days of analysis (n = 5 for each day) with baseline noise calcu-
lated as peak-to-peak noise directly adjacent to the -KgCN peak.
Precision was  calculated as a percent relative standard deviation
(%RSD) by dividing the standard deviation by the mean for each cal-
ibrator and QC standard. Accuracy (%) was determined by dividing
the calculated concentration by the nominal concentration for each
calibrator and QC standard. A %RSD of less than 15% and a percent
accuracy of 100 ± 20% were used as criteria for inclusion of calibra-
tion standards and determination of the ULOQ and LLOQ. Stability
was calculated as a percentage by dividing the concentration of the
QC standard (low or high) from each time point (days or hours) by
the concentration of the QC standard at time zero (the control). The
-KgCN was considered stable under a particular storage condition
if this ratio was  ≥85%.
3. Results and discussion
3.1. Analysis of ˛-KgCN from swine plasma
The mass spectra of -KgCN and -KgCN-d4 produced by ESI(−)-
MS are shown in Fig. 2. Fig. 2A shows the mass spectrum of -KgCN
with the ions important for the analysis of -KgCN identified. The
m/z ratio of 172.0 corresponds to the molecular ion of -KgCN with
the loss of a proton ([M−H]−). The m/z ratio of 144.7 corresponds to
the molecular ion of the precursor, -Kg, minus a proton. The m/z
ratio of 101.0 corresponds to the loss of a carboxyl group from -Kg.
The m/z ratio of 44.8 is a common fragment for a carboxyl group.
ESI(−)-MS was also conducted on -KgCN-d4 and its mass spec-
trum is shown in Fig. 2B. -KgCN-d4 showed similar fragmentation
compared with -KgCN with the exception of a mass difference of
+4 m/z for each major fragment, besides m/z 44.8, because of the
replacement of 4 hydrogen atoms with deuterium atoms in the
labeled compound.
Fig. 3 shows representative chromatograms of -KgCN spiked
swine plasma and cyanide-exposed swine plasma (pre- and post-
exposure). The -KgCN elutes at approximately 1.6 min with some
degree of tailing, which is most likely caused by the interaction of
exposed silica support with -KgCN. The tailing did not interfere
with quantification of -KgCN. Furthermore, the method shows
excellent selectivity for -KgCN as shown by the absence of co-
eluting peaks in the pre-exposure swine plasma chromatogram. In
fact, no other peaks are seen in the pre-exposure swine plasma
chromatogram.
3.2. Linear dynamic range
Standard curves were generated in the range of 0.2–300 M
-KgCN in swine plasma. Calibration standards at 0.2, 100, and
300 M were found to be outside the LLOQ or ULOQ, resulting in a
linear dynamic range from 0.3 to 50 M as described by a weighted
(1/x2) curve validated over 3 separate days of analysis (within 9
calendar days). Therefore, the dynamic range of -KgCN in swine
plasma is over 2 orders of magnitude. The LOD was found to be
200 nM -KgCN in swine plasma validated over a 7-day period with
3 separate days of analysis (n = 7 for each day).
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Fig. 2. ESI(−) mass spectra of -KgCN (A) and -KgCN-d4 (B) with identification of the abundant ions. (A) The -KgCN ion at 172.0 m/z corresponds to [M−H]− and the
ion  at 144.7 m/z corresponds to [-Kg-H]− , the precursor to -KgCN. (B) The -KgCN-d4 ion at 176.1 m/z corresponds to [M−H]− and the ion at 149.1 m/z corresponds to
[-Kg-d4-H]− . Insets: Structures of -KgCN (A) and -KgCN-d4 (B) with abundant fragments indicated.
3.3. Accuracy and precision
The intra- and inter-assay accuracy and precision were evalu-
ated for low, medium, and high QC standards over 3 days of analysis
(Table 2). The method produced good accuracy and precision for the
concentrations tested, with intra-assay precision ≤11% and inter-
assay precision ≤13% for all QC standards, and accuracy within
±10% of the nominal QC concentration. The accuracy and preci-
sion of analytical methods are typically considered acceptable if the
%RSD (precision) is less than 15% and the percent accuracy of back-
calculated concentrations is between 80% and 120% as compared
to the nominal concentration.
3.4. Stability and recovery
The short-term stability of -KgCN in swine plasma was  evalu-
ated on the bench-top and in the autosampler over 24 h. Prepared
samples of -KgCN exhibited excellent stability in the autosampler,
with no more than 15% deviation from the control. Furthermore,
freeze-thaw experiments showed that -KgCN was stable in swine
plasma at −80 ◦C over the 3 cycles tested. Conversely, the bench-top
stability of -KgCN was poor with -KgCN concentrations falling
significantly below 85% of the control within 2 h, showing that
-KgCN is quickly eliminated from swine plasma at room temper-
ature.
The long-term stability of -KgCN was  evaluated for 30 days
at −80, −20 and 4 ◦C. The -KgCN was stable for 30 days at
−80 ◦C, for 1 day at −20 ◦C, and was quickly eliminated at 4 ◦C,
for both low and high QC concentrations. The results of the
long-term study suggest that -KgCN spiked swine plasma sam-
ples should be stored at −80 ◦C when possible. If samples need
to be stored at −20 ◦C, they should be analyzed as soon as
possible. Storage at >−20 ◦C is not recommended for plasma
samples.
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Table  2
The accuracy and precision of -KgCN in swine plasma by UHPLC–MS–MS.
Nominal concentration (M) Intra-assay accuracy (%)a Inter-assay accuracy (%)b Intra-assay precision (%RSD)a Inter-assay precision (%RSD)b
0.75 100 97 11 8.9
4  110 104 11 13
20  107 104 5.0 8.4
a Mean for 1 day of validation (n = 5).
b Mean for 3 days of validation (n = 15).
0 1 2 3 4 5 6
Time (min)
Spiked (1 µM)
Post -ex pos ure
Pre -ex pos ure
Ab
un
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nc
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Fig. 3. Chromatograms of -KgCN spiked swine plasma (upper trace) and the
plasma of cyanide-exposed swine, pre-exposure (lower trace), and post-exposure
(middle trace). The chromatograms represent the signal response of the MRM  tran-
sition 172.0→145.1 m/z.
The recovery of -KgCN from swine plasma at low, medium,
and high QC concentrations was 14%, 22%, and 27%, respectively.
Acidification of the swine plasma before spiking in -KgCN, did
not significantly increase the recovery (25%, 23%, and 30% for low,
medium and high QC standards, respectively). Heating the swine
plasma to precipitate proteins and cooling back to room tempera-
ture before spiking in -KgCN actually decreased the recovery (7%,
4%, and 4% for low, medium, and high QC standards, respectively).
Because enzyme activity should at least be reduced when heating
and acidifying the plasma, the consistently low recovery is most
likely due to facile equilibrium between -Kg and -KgCN. Conse-
quently, cyanide may  undergo various side reactions that remove
it from the swine plasma such as protein binding [3,14], ATCA for-
mation [7,32], or evaporation of HCN [4,33]. Further experiments
will be considered to address these concerns. A potential avenue
for future research in this area would be to compare -KgCN spiked
aqueous and plasma samples by mass spectral analysis to elucidate
reactions involving -KgCN.
3.5. The analysis of cyanide-exposed swine plasma
The described method was applied to the analysis of -KgCN
in plasma samples obtained from cyanide-exposed swine. Fig. 3
shows representative chromatograms of plasma collected from
swine before and after cyanide exposure. The peak for -KgCN
observed around 1.6 min  and the absence of co-eluting peaks in
the pre-exposed swine sample indicate that the analysis is selective
for -KgCN. Overall, the results indicate that the analytical method
presented can be used to quickly and easily analyze -KgCN in the
plasma of cyanide-exposed swine.
3.6. ˛-KgCN as a marker of cyanide exposure
The suggested use of -KgCN as a cyanide biomarker was
confirmed with the observation of -KgCN in the plasma of
cyanide-exposed swine after exposure (Fig. 3). The major advan-
tage of using -KgCN as a biomarker is that it was not detected
endogenously in the plasma. The disadvantages of using -KgCN as
a cyanide marker are poor recovery and limited stability in plasma.
Although the stability of -KgCN was poor under most conditions,
it was  shown to be stable for at least 30 days at −80 ◦C, which is sig-
nificantly better than cyanide and thiocyanate in plasma (found to
be stable for 2 and 5 days, respectively [34]) but worse than ATCA
(found to be stable for at least 3 months under a variety of stor-
age conditions [7]). Further studies on the toxicokinetic behavior
of -KgCN were undertaken in order to further evaluate its use as
a marker of cyanide poisoning [35].
4. Conclusions
An analytical method for the determination of -KgCN, a poten-
tial alternative marker of cyanide exposure, was created and
validated. This method shows the ability to detect -KgCN in swine
plasma at low concentrations, as indicated by an LOD of 200 nM.
Furthermore, -KgCN can be quantified accurately and precisely
in swine plasma, at sub-M concentrations. The method allows
-KgCN to serve as a biological marker for cyanide exposure and
should aid in studies of therapeutic treatment of cyanide exposure
with -Kg. Future work will include the application of the method
to analyze -KgCN from the plasma of cyanide-exposed swine and
investigations pertaining to the low recovery of -KgCN from swine
plasma. To our knowledge, the method developed here is the first
reported analytical method for detecting the cyanide detoxification
product, -KgCN, in any matrix.
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